000			01936 a2200529 4500
005			20250515024608.0
264		0	_c20060831
008			200608s 0 0 eng d
022			_a1073-449X
024	7		_a10.1164/rccm.200603-360OC _2doi
040			_aNLM _beng _cNLM
100	1		_aBurman, William J
245	0	0	_aMoxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. _h[electronic resource]
260			_bAmerican journal of respiratory and critical care medicine _cAug 2006
300			_a331-8 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAfrica
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aAza Compounds _xadverse effects
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEthambutol _xadverse effects
650	0	4	_aFemale
650	0	4	_aFluoroquinolones
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMoxifloxacin
650	0	4	_aMycobacterium tuberculosis _xisolation & purification
650	0	4	_aQuinolines _xadverse effects
650	0	4	_aSputum _xmicrobiology
650	0	4	_aTuberculosis, Pulmonary _xdrug therapy
650	0	4	_aUnited States
700	1		_aGoldberg, Stefan
700	1		_aJohnson, John L
700	1		_aMuzanye, Grace
700	1		_aEngle, Melissa
700	1		_aMosher, Ann W
700	1		_aChoudhri, Shurjeel
700	1		_aDaley, Charles L
700	1		_aMunsiff, Sonal S
700	1		_aZhao, Zhen
700	1		_aVernon, Andrew
700	1		_aChaisson, Richard E
773	0		_tAmerican journal of respiratory and critical care medicine _gvol. 174 _gno. 3 _gp. 331-8
856	4	0	_uhttps://doi.org/10.1164/rccm.200603-360OC _zAvailable from publisher's website
999			_c16277071 _d16277071